Product Overview

Glimepiride 2 mg is a prescription oral antihyperglycemic agent indicated for the management of type 2 diabetes mellitus. Manufactured by Sun Pharmaceutical Industries Ltd, each strip contains ten film‑coated tablets delivering a consistent 2 milligram dose of glimepiride. The medication is formulated to help lower blood glucose levels when used in conjunction with diet and exercise. Packaged in a convenient strip of ten tablets, the product is available in three pack sizes – 60, 90, and 120 tablets – to accommodate varying treatment durations. Delivery typically occurs within six to fifteen days, depending on the shipping destination.

What is Glimepiride 2 mg?

Glimepiride belongs to the sulfonylurea class of antidiabetic drugs. It functions by stimulating pancreatic beta‑cells to increase insulin secretion, thereby reducing fasting and post‑prandial glucose concentrations. The 2 mg strength is the most commonly prescribed dose for adults with type 2 diabetes who have not achieved adequate control with metformin alone. As a generic formulation, it contains the same active ingredient as the branded version but is offered at a cost‑effective price point. The drug is listed in the United States Pharmacopeia (USP) and meets FDA standards for identity, strength, purity, and potency.

Uses and Benefits

Clinicians prescribe glimepiride 2 mg to improve glycemic control in patients with type 2 diabetes who have not responded adequately to lifestyle changes or metformin therapy. The drug can be taken once daily with or without food, offering flexible dosing. When used together with a healthy diet and regular exercise, it helps maintain target glucose levels and may lower the risk of diabetes‑related complications such as nerve damage, eye problems, and heart disease. Guidance on diabetes care is provided by resources such as the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases.

How It Works

The pharmacologic action of glimepiride centers on the closure of ATP‑sensitive potassium channels on pancreatic beta‑cells. This blockade leads to an influx of calcium ions, triggering exocytosis of insulin granules. The resulting increase in endogenous insulin production lowers blood glucose levels without requiring exogenous insulin administration. Unlike some other sulfonylureas, glimepiride exhibits a relatively long half‑life, allowing for once‑daily dosing. Its hepatic metabolism primarily occurs via the cytochrome P450 enzyme system, with the majority of the drug eliminated through the kidneys. Because insulin secretion is glucose‑dependent, the risk of hypoglycemia is present but can be minimized by adhering to recommended dosing schedules and monitoring blood glucose regularly.

Dosage Guidelines

Typical initiation of glimepiride therapy begins with a 1 mg dose taken once daily, which may be titrated upward by 1 mg increments at intervals of 1 to 2 weeks based on glycemic response. The maximum recommended daily dose is 8 mg, divided into two doses if necessary. For most patients, a stable maintenance dose of 2 mg once daily provides adequate glycemic control. Tablets should be swallowed whole with a glass of water; they must not be crushed or split unless directed by a healthcare professional. Patients with renal impairment may require dose adjustment, as the drug is primarily excreted unchanged in the urine. Regular monitoring of renal function and blood glucose is advised to determine the appropriate dose. For detailed prescribing information, refer to the FDA drug label guidance.

Side Effects

Like all medications, glimepiride can cause adverse effects. The most frequently reported side effects include hypoglycemia, dizziness, headache, and gastrointestinal discomfort such as nausea. Rare but serious reactions may involve skin rash, pruritus, or hypersensitivity responses that necessitate discontinuation of therapy. In very rare cases, hematologic abnormalities such as neutropenia or thrombocytopenia have been documented. Patients should be instructed to recognize early signs of low blood sugar, including sweating, shakiness, confusion, and rapid heartbeat, and to treat hypoglycemia promptly with glucose‑containing foods or glucose tablets. If side effects persist or worsen, medical attention should be sought. For comprehensive safety data, consult the Drugs.com drug information database.

Warnings and Precautions

Glimepiride is contraindicated in patients with type 1 diabetes mellitus or diabetic ketoacidosis. Caution is advised in individuals with a history of cardiovascular disease, hepatic impairment, or severe renal dysfunction, as these conditions may increase the risk of hypoglycemia or drug accumulation. Concomitant use of certain medications, such as non‑steroidal anti‑inflammatory drugs (NSAIDs), certain antibiotics, and some antifungals, can potentiate hypoglycemic episodes. Alcohol consumption should be limited, as it can enhance the risk of low blood glucose. Pregnant or breastfeeding women should avoid glimepiride unless deemed essential by a qualified healthcare provider. Routine laboratory monitoring, including liver function tests and creatinine clearance, is recommended during long‑term therapy. Always discuss new medications and dosage changes with a prescribing clinician.

Frequently Asked Questions

1. The typical starting dose of glimepiride is 1 mg once daily, with possible increases of 1 mg at weekly intervals based on blood‑glucose response. A common maintenance dose is 2 mg once daily. Dose adjustments are guided by regular glucose monitoring and HbA1c testing. Take the tablet whole with water; do not crush or split it unless directed. If you miss a dose, take it as soon as you remember unless it is near the time of your next dose, then skip it and continue your regular schedule.
2. The medication can be used together with other antidiabetic agents such as metformin, but only under medical supervision. Combining therapies may enhance glucose control, yet it also raises the risk of hypoglycemia, so blood‑sugar levels must be checked more frequently. Your physician will determine the appropriate combination based on your individual health profile, kidney function, and other medications. Never start, stop, or change the dose of any diabetes drug without consulting a qualified healthcare professional.
3. Store glimepiride tablets at room temperature, away from moisture and heat, and keep the strip tightly closed until you are ready to take a dose. Do not refrigerate or expose the medication to excessive sunlight. Keep the medication out of reach of children and pets, and dispose of any expired or unused tablets according to local waste‑disposal regulations. If you experience any adverse effects or notice changes in your health, contact your healthcare provider promptly.
4. If a dose is missed, take it as soon as you remember provided it is not close to the time of your next scheduled dose; otherwise, skip the missed dose and continue with your regular dosing schedule. Do not double up on doses to make up for a missed one, as this can increase the risk of hypoglycemia. If you are uncertain about whether to take a missed dose, consult your prescribing clinician for guidance. Consistency in dosing helps maintain steady blood‑glucose control and reduces the likelihood of side effects.
5. Elderly patients often require lower doses of glimepiride because kidney function may decline with age, increasing the risk of hypoglycemia. Start with a reduced dose, such as 0.5 mg once daily, and adjust slowly based on blood‑glucose monitoring. Regular renal function tests are recommended, and any signs of low blood sugar — such as dizziness, confusion, or palpitations — should be reported immediately. Always discuss dose changes with a healthcare professional before implementing them.

Related Products

• Famotidine 20mg (Generic)
• Omesec 20 mg (Omeprazole)
• Pantocid DSR (Pantoprazole/Domperidone)
• Famotidine 40mg (Generic)
• Famocid 20mg (Famotidine)
• Famocid 40mg (Famotidine)
• Famocid (Famotidine)
• Supatret 0.04% Gel (Tretinoin)
• Supatret 0.1% Gel (Tretinoin)
• Supatret C Gel (Clindamycin/Tretinoin)
• Supatret Gel (Tretinoin)
• Acitretin 25mg (Generic)